Skip to content

Charles River Laboratories CRL Impairment of intangible assets

Discontinued — last reported Q4 '25

Impairment of intangible assets at other companies

General Motors logo
General MotorsGM
$35.5M0.0%
Teledyne Technologies logo
Teledyne TechnologiesTDY
$0-100%
Ciena logo
CienaCIEN
$22.28M
Deckers Outdoor Corporation logo
Deckers Outdoor CorporationDECK
$0
StoneX Group Inc. logo
StoneX Group Inc.SNEX
$4.6M-71.6%
Regal Rexnord logo
Regal RexnordRRX
$0

Segments

By segment

See full
RMS$211M
Manufacturing$108.97M

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfIntangibleAssetsFinitelived.

The official record: Charles River Laboratories’s 10-K, filed February 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's impairment of intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's impairment of intangible assets?
Charles River Laboratories (CRL) reported impairment of intangible assets of $52.74M in Q4 2025.
What does impairment of intangible assets mean?
This metric represents the reduction in the carrying value of finite-lived intangible assets when their fair value falls below their book value. It indicates that the expected future economic benefits from assets like patents, trademarks, or customer lists have declined. Frequent impairments may suggest poor historical acquisition decisions or rapid technological obsolescence.